Case number 1:19-cv-00768
Teijin Limited et al v. Alkem Laboratories Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 1 | Complaint (15) |
| Oct 10, 2019 | 23 | Patent/Trademark Report to Commissioner (1) |
| Oct 10, 2019 | 23 | Order (3) |
| Oct 10, 2019 | 23 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,361,676 B2; 8,372,872 B2; 9,107,912 B2. (Attachments: # (1) Order)(nms) |
| Oct 9, 2019 | 22 | Order (3) Docket Text: SO ORDERED Granting [21] Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 10/9/2019. (nms) |
| Oct 8, 2019 | 21 | Stipulation of Dismissal (3) Docket Text: STIPULATION of Dismissal, by Takeda Pharmaceuticals U.S.A., Inc., Teijin Limited, Teijin Pharma Limited. (Jacobs, Karen) Modified on 10/9/2019 (nms). |
| Oct 3, 2019 | 20 | Redacted Document (1) Docket Text: REDACTED VERSION of [18] Letter by Takeda Pharmaceuticals U.S.A., Inc., Teijin Limited, Teijin Pharma Limited. (Jacobs, Karen) |
| Sep 27, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The request to submit a further update (D.I. [18]) by October 10, 2019, is APPROVED. Ordered by Judge Richard G. Andrews on 9/27/2019. (nms) |
| Sep 19, 2019 | 16 | Letter (1) Docket Text: Joint Letter to The Honorable Richard G. Andrews, from Karen Jacobs ,regarding further status report. (Jacobs, Karen) Modified on 9/19/2019 (nms). |
| Sep 19, 2019 | N/A | Oral Order (0) |
| Sep 16, 2019 | N/A | Redaction Notice (0) Docket Text: REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI #[13]. (nms) |
| Sep 16, 2019 | 15 | Redacted Document (1) Docket Text: REDACTED VERSION of [13] Letter by Takeda Pharmaceuticals U.S.A., Inc., Teijin Limited, Teijin Pharma Limited. (Jacobs, Karen) |
| Sep 5, 2019 | N/A | Oral Order (0) |
| Aug 15, 2019 | 11 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews from Karen Jacobs regarding the parties respectfully request that the August 21, 2019 scheduling conference be taken off the calendar. (Jacobs, Karen) |
| Aug 15, 2019 | N/A | Oral Order (0) |
| Jun 21, 2019 | 9 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Alkem Laboratories Limited. (Farnan, Brian) |
| Jun 21, 2019 | 10 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Alkem Laboratories Limited for Ascend Laboratories, LLC filed by Ascend Laboratories, LLC. (Farnan, Brian) |
| Jun 20, 2019 | 8 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 8/21/2019, at 11:30 AM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 6/20/2019. (nms) |
| Jun 18, 2019 | 7 | Answer to Complaint (8) Docket Text: ANSWER to [1] Complaint, by Alkem Laboratories Limited, Ascend Laboratories, LLC.(Farnan, Brian) |
| May 1, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Apr 29, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Alkem Laboratories Limited on 4/29/2019; Ascend Laboratories, LLC on 4/29/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Apr 26, 2019 | 1 | Exhibit A-I (174) |
| Apr 26, 2019 | 1 | Civil Cover Sheet (1) |
| Apr 26, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Apr 26, 2019 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/16/2019. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 9/15/2021. (nmg) |
| Apr 26, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,361,676 B2; 8,372,872 B2; 9,107,912 B2. (nmg) |
| Apr 26, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teijin Limited for Teijin Pharma Limited filed by Teijin Limited, Teijin Pharma Limited. (nmg) |
| Apr 26, 2019 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Limited, Corporate Parent Takeda Pharmaceuticals International, AG for Takeda Pharmaceuticals U.S.A., Inc. filed by Takeda Pharmaceuticals U.S.A., Inc. (nmg) |
| Apr 26, 2019 | 1 | Main Document (15) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Alkem Laboratories Limited and Ascend Laboratories, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2629336.) - filed by Teijin Pharma Limited, Teijin Limited, Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # (1) Exhibit A-I, # (2) Civil Cover Sheet)(nmg) |
| Apr 26, 2019 | 1 | Complaint* (1) |
